Events

Antimicrobial resistance is an increasingly serious threat to global public health that requires action across all government sectors and society. BioInfect will look at the critical issues relating to the […]

Kevin Outterson is the N Neal Pike Professor of Health and Disability Law at Boston University and the Executive Director of CARB-X, the world’s largest product development partnership addressing drug-resistant bacterial infections. […]

The All-Party Parliamentary Group on Antibiotics APPG-A exists to raise the profile of antibiotic resistance, the need to preserve antibiotics through education on their appropriate use including non‐human uses, the lack […]

This webinar aims at making a presentation of a recent GARDP co-organized conference session accessible to anyone who didn't have the chance to attend the meeting. After the showing of […]

Additional details to follow.   Presentation by Kevin Outterson, Executive Director of CARB-X.

Wellcome Trust is to co-host a second global conference  to help drive pioneering action to stop the rise and spread of superbugs.  The two-day Call to Action, taking place in […]

This event is an invitation-only side event to the 2nd Call to Action on Antimicrobial Resistance hosted by the Access to Medicine Foundation, the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) and […]

Speakers include Karen Gallant, Global Program Director of CARB-X.

With Kevin Outterson.  A Boston University Alumni Association special webinar event for BU alumni, but all are welcome to join. Register online

The European Clinical Research Alliance on Infectious Diseases (ECRAID) focuses on two major challenges: emerging infectious diseases (EID) with epidemic or pandemic potential, caused by new or re-emerging pathogens, and antimicrobial […]